These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 21343951)
1. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951 [TBL] [Abstract][Full Text] [Related]
2. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome. Busa T; Milh M; Degardin N; Girard N; Sigaudy S; Longy M; Olshchwang S; Sobol H; Chabrol B; Philip N Eur J Paediatr Neurol; 2015 Mar; 19(2):188-92. PubMed ID: 25549896 [TBL] [Abstract][Full Text] [Related]
3. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations. Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080 [TBL] [Abstract][Full Text] [Related]
4. Novel PTEN germline mutation in a family with mild phenotype: difficulties in genetic counseling. Busa T; Chabrol B; Perret O; Longy M; Philip N Gene; 2013 Jan; 512(2):194-7. PubMed ID: 23124040 [TBL] [Abstract][Full Text] [Related]
5. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol. Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798 [TBL] [Abstract][Full Text] [Related]
6. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284 [TBL] [Abstract][Full Text] [Related]
7. Novel dermatological and skeletal features associated with PTEN variant in PTEN hamartoma tumor syndrome. Comeau D; Allain V; Maillet-Lebel N; Ben Amor M Eur J Med Genet; 2023 Aug; 66(8):104798. PubMed ID: 37307869 [TBL] [Abstract][Full Text] [Related]
8. Imaging of PTEN-related abnormalities in the central nervous system. Dhamija R; Hoxworth JM Clin Imaging; 2020 Apr; 60(2):180-185. PubMed ID: 31927175 [TBL] [Abstract][Full Text] [Related]
9. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity. Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk and clinical implications for germline PTEN mutation carriers. Ngeow J; Sesock K; Eng C Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035 [TBL] [Abstract][Full Text] [Related]
12. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. Lachlan KL; Lucassen AM; Bunyan D; Temple IK J Med Genet; 2007 Sep; 44(9):579-85. PubMed ID: 17526800 [TBL] [Abstract][Full Text] [Related]
13. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993 [TBL] [Abstract][Full Text] [Related]
14. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes. Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968 [TBL] [Abstract][Full Text] [Related]
15. PTEN: one gene, many syndromes. Eng C Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083 [TBL] [Abstract][Full Text] [Related]
16. Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases. Hendriks YM; Verhallen JT; van der Smagt JJ; Kant SG; Hilhorst Y; Hoefsloot L; Hansson KB; van der Straaten PJ; Boutkan H; Breuning MH; Vasen HF; Bröcker-Vriends AH Fam Cancer; 2003; 2(2):79-85. PubMed ID: 14574156 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical/molecular characteristics of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly. Kaymakcalan H; Kaya İ; Cevher Binici N; Nikerel E; Özbaran B; Görkem Aksoy M; Erbilgin S; Özyurt G; Jahan N; Çelik D; Yararbaş K; Yalçınkaya L; Köse S; Durak S; Ercan-Sencicek AG Mol Genet Genomic Med; 2021 Aug; 9(8):e1739. PubMed ID: 34268892 [TBL] [Abstract][Full Text] [Related]
18. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Butler MG; Dasouki MJ; Zhou XP; Talebizadeh Z; Brown M; Takahashi TN; Miles JH; Wang CH; Stratton R; Pilarski R; Eng C J Med Genet; 2005 Apr; 42(4):318-21. PubMed ID: 15805158 [TBL] [Abstract][Full Text] [Related]
19. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. Pilarski R; Stephens JA; Noss R; Fisher JL; Prior TW J Med Genet; 2011 Aug; 48(8):505-12. PubMed ID: 21659347 [TBL] [Abstract][Full Text] [Related]